Skip to main content

Table 2 Characteristics of the participants, WB-MRI results, and additional investigations

From: Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals

 

Value (Interquartile range)

Characteristic

Overall

(n = 2064)

Median age (yr)

55 (45–63)

Male (%)

1120 (54.3)

Median measured height (cm)

165 (158.8–171.6)

Median measured weight (kg)

65.2 (56.5–75)

Median measured body mass index (kg/m2)

23.9 (21.6–26.5)

Median measured systolic blood pressure (mmHg)

121 (109–135)

Median measured diastolic blood pressure (mmHg)

76 (70–83)

Median measured heart rate (bpm)

71 (64–79)

Hypertension (%)

466 (22.6)

Coronary artery disease (%)

144 (7)

Diabetes mellitus (%)

185 (9)

Hepatitis B carrier (%)

196 (9.5)

Hepatitis C (%)

17 (0.8)

Cancer cured for ≥ 5 yrs (%)

51 (2.5)

Surgical history (%)

372 (18)

Family history of cancer (%)

863 (41.8)

WB-MRI results (%)

 

ONCO-RADS category 1

0 (0)

ONCO-RADS category 2

1984 (96.1)

ONCO-RADS category 3

37 (1.8)

ONCO-RADS category 4

35 (1.7)

ONCO-RADS category 5

8 (0.4)

Additional investigations (%)

 

CT (%)

28 (1.4)

Median interval between CT and WB-MRI (day)

1 (0–22)

Dedicated MRI (%)

7 (0.3)

Median interval between dedicated MRI and WB-MRI (day)

75 (32–1415)

Histopathology examination (%)

42 (2)

Median interval between histopathology and WB-MRI (day)

36 (19–55)

Cancer

24 (1.2)

Confirmed by imaging only

2 (0.1)

Confirmed by histopathology

22 (1.1)

  1. WB-MRI = whole-body magnetic resonance imaging; ONCO-RADS = Oncologically Relevant Findings Reporting and Data System; CT = computed tomography